(Total Views: 95)
Posted On: 06/21/2021 10:00:50 AM
Post# of 144774
$AVXL News Article - Anavex Life Sciences Announces ANAVEX 2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome https://marketwirenews.com/news-releases/anav...36866.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
